BioXcel Therapeutics, Inc. (BTAI) Stock Price, News, Quote

Find the latest BioXcel Therapeutics, Inc. (BTAI) stock quote, history, news and other vital information to help you with your stock trading and investing.

CouponFollow Extension

$127
OFF

BTAI Stock Price | BioXcel Therapeutics Inc. Stock Quote (U.S.: …

6 days from now

4 days ago · BioXcel Therapeutics price target cut to $127 from $150 at Truist Securities, stock rated buy. Apr. 1, 2021 at 6:59 a.m. ET by Tonya Garcia.

marketwatch.com

$25
OFF

BioXcel Therapeutics, Inc. (BTAI) Stock Price, Quote & News

6 days from now

BioXcel Therapeutics Announces $25 Million Registered Direct Offering. NEW HAVEN, Conn., March 25, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) …

stockanalysis.com

$0.57
OFF

Bioxcel Therapeutics Stock Price Today (NASDAQ: BTAI) Quote, …

6 days from now

Nov 15, 2024 · With Bioxcel Therapeutics stock trading at $0.57 per share, the total value of Bioxcel Therapeutics stock (market capitalization) is $23.14M. Bioxcel Therapeutics stock was …

wallstreetzen.com

$60
OFF

BioXcel Therapeutics (BTAI) Stock Price, News & Analysis

6 days from now

1 day ago · BioXcel Therapeutics (BTAI) raised $60 million in an initial public offering on Thursday, March 8th 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 …

marketbeat.com

26%
OFF

BTAI - BioXcel Therapeutics Inc Stock Price And Quote - FINVIZ.com

6 days from now

Why Is BioXcel Therapeutics (BTAI) Stock Down 26% Today? (InvestorPlace)-43.73%. Feb-08-24 04:01PM ... Why BioXcel Therapeutics Stock Flopped Again Today (Motley Fool) 09:59AM …

finviz.com

$7
OFF

BioXcel Therapeutics, Inc. Stock (BTAI) - Quote Nasdaq

6 days from now

Nov 11, 2024 · Canaccord Genuity Cuts Price Target on BioXcel Therapeutics to $7 From $20, Maintains Buy Rating. Mar. 14. MT. UBS Adjusts BioXcel Therapeutics Price Target to $3.50 …

marketscreener.com

$6.50
OFF

What To Expect From BioXcel Therapeutics Inc (BTAI) Q3 2024 …

6 days from now

Nov 13, 2024 · Based on the one-year price targets offered by 6 analysts, the average target price for BioXcel Therapeutics Inc (NASDAQ:BTAI) is $6.50 with a high estimate of $18 and a low …

yahoo.com

$0
OFF

BioXcel Therapeutics Stock Hits 52-week Low At $0.5 - Investing.com

6 days from now

1 day ago · In a challenging market environment, BioXcel Therapeutics Inc . (NASDAQ: BTAI) stock has recorded a new 52-week low, dipping to $0.5. This latest price level reflects a …

investing.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …

globenewswire.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

BioXcel Therapeutics (NASDAQ:BTAI) on Friday announced the pricing of an underwritten public offering of 5.6M shares of its common stock and accompanying warrants to purchase up to …

msn.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

1 day ago · BioXcel Therapeutics (NASDAQ:BTAI) on Friday announced the pricing of an underwritten public offering of 5.6M shares of its common stock and accompanying warrants …

seekingalpha.com

$179.05
OFF

BioXcel Therapeutics (BTAI) Earnings Date And Reports 2024

6 days from now

5 days ago · Get the Latest News and Ratings for BTAI and Related Stocks. ... BioXcel Therapeutics (NASDAQ:BTAI) has a recorded net income of -$179.05 million. BTAI has …

marketbeat.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

bioxceltherapeutics.com

FAQs about BioXcel Therapeutics, Inc. (BTAI) Stock Price, News, Quote Coupon?

Who owns bioxcel Therapeutics Inc?

It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT. BTAI | Complete BioXcel Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

What is btai - bioxcel Therapeutics Inc?

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, historical statements, and much more. BTAI - BioXcel Therapeutics Inc - Stock screener for investors and traders, financial visualizations. ...

When will bioxcel Therapeutics Inc (btai) release its Q3 2024 earnings?

BioXcel Therapeutics Inc (NASDAQ:BTAI) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 2024 revenue is $1.31 million, and the earnings are expected to come in at -$0.60 per share. The full year 2024's revenue is expected to be $4.70 million and the earnings are expected to be -$2.30 per share. ...

Will bioxcel Therapeutics (btai) revert to a trend reversal?

This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of 72.37% and 38%, respectively, for the quarter ended June 2024. ...

What time will bioxcel Therapeutics' financial results be released?

Conferencecallset for 8:00a.m.ETtoday NEW HAVEN, Conn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced its financial results for the third quarter of 2024. ...

Is bioxcel Therapeutics (btai) a hammer chart reversal?

BioXcel Therapeutics (BTAI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. ...